Oncotarget is a scientific journal that is published every week to avail all discoveries and developments made especially in the field of oncology. Oncology is a vast topic, and in its definition, it is a multi-disciplinary subject that encompasses other areas such as cancer cells, neurodegradation atherosclerosis, lymphocytes, microbes, molecules, and cellular functions in cancerous cells. With this all fields under Oncology, Oncotarget as a scientific journal surely has a big responsibility of being able to gather up all new findings from researchers, establishing the credibility of the results before publishing.The aim of publishing these findings by Oncotarget is to be able to pass out the new information to the many interested scientists all over the world. The new data helps this scientist to be at par with each other as they collectively wage a united war on finding a cure for cancer and other diseases. For this purpose, the scientific journal is the link where one can obtain these new breakthroughs and developments.
For more than a decade and a half now Oncotarget has been able to publish quite some scientific papers all backed up with incredible evidence making it one of the most reputable scientific journals in the world. This has made it acquire a big following in the scientific community, and as such making, it stands out from other scientific journals.Other aspects have made the journal stand out even more, and such include being able to avail new clear break troughs much quicker than others.
This has been aided by the journal publishers to embark on a fact finding missions quickly when a result has been submitted to them for review. The journals first ability to link the many multidisciplinary subjects under Oncology is a unique aspect of the journal that has driven the common goal to find a cure so as to eradicate cancer completely and faster.The journal, also, does include in its publishing the developments in the treatment of cancer. Such events published involves the impacts of new therapies on patients using new therapeutics, their effects, protocols used, and the ultimate effectiveness and response by the patients themselves.